HO-1 drives autophagy as a mechanism of resistance against HER2-targeted therapies.
Natasha TraceyHelen CreedonAlain J KempJayne CulleyMorwenna MuirTeresa KlinowskaValerie G BruntonPublished in: Breast cancer research and treatment (2019)
Together these data indicate a role for HO-1-induced autophagy in resistance to pan-HER family kinase inhibitors.